Introduction: Thyroidectomy is one of the most frequently performed surgical procedures worldwide. The most common complication of total thyroidectomy (TT) in the early postoperative period is hypocalcemia. This study aims to determine the risk factors for postoperative hypocalcemia after TT and to reveal their clinical value. As a secondary outcome, we assessed the effects of iatrogenic parathyroidectomy, surgical experience, and parathyroid transplantations on prolonged than one month hypocalcemia and intravenous calcium infusion requirement after TT.Methods: We designed our study as a retrospective cohort study. Two hundred sixty-three patients that underwent total thyroidectomy in a single tertiary endocrine surgery unit were included. Patients are followed up for 6 months. The study performed between April 2014 and March 2015. Patients were divided into two groups according to the presence or absence of hypocalcemia after surgery. All patients who performed total thyroidectomy without lymph node dissection in a single session were initially included in the study cohorts. Thereafter, patients with preoperatively confirmed hyperparathyroidism, hypoparathyroidism/hypocalcemia, had a history of thyroid operation, and postoperatively did not undergo regular follow-up (min. 12 months after surgery) were excluded from the latter analysis.Results: In the multivariate analysis we conducted in our study, we found that female gender, preoperative hyperthyroidism, intraoperative parathyroid autotransplantation, and surgical experience were independent risk factors. Some of them are predictable parameters such as surgeon experience and preoperative hyperthyroidism.Conclusions: We consider that specific theoretical and practical studies on thyroid surgery will reduce postoperative hypocalcemia.
11 March 2024 in Turkish Journal of Colorectal Disease
Aim To compare the short-term results of open and laparoscopic gastrectomy in gastric cancer surgery. Material and Method From 15 May 2018 to 28 June 2021, patients who underwent open and laparoscopic gastrectomy for gastric cancer by a single surgeon between were retrospectively analyzed from a prospectively maintained database. Patients were compared in terms of early intraoperative and postoperative outcomes. Both surgical methods were compared in terms of early intraoperative and postoperative outcomes. Results A total of 34 patients (open n = 23, laparoscopic n = 11) were included in the study. While the mean number of lymph nodes was similar between the groups, more metastatic lymph nodes and more advanced disease were detected in the open group (p = 0.007, p = 0.002, respectively). According to tumor location, patients who underwent laparoscopic gastrectomy were more distally located (p = 0.01). The mean operative time was shorter in the open group (171.5 min and 206 min, p = 0.006, respectively), while the estimated blood loss was less in the laparoscopic group (158.2 mL vs 186.7 mL, p = 0.003). Four patients (17.4%) in the open group and two patients (18%) in the laparoscopic group had at least Clavien-Dindo grade III complications (p=0.96). Earlier gas output was seen in the laparoscopic group (p = 0.002), while other postoperative outcomes were similar between the groups. Mean follow-up time was longer in the open group (13.4 months and 7.6 months, respectively, p = 0.004). Conclusion Until sufficient experience is reached in laparoscopic gastrectomy, choosing earlier stage and distally located tumors is a safe method with postoperative results similar to open gastrectomy.
Background: Recurrence of anal fistulas represents one of the most frequently encountered complications in fistula management and remains a dilemma. Studies investigating the histological structure of fistulas and their relationship with recurrence are extremely limited. Objective: To evaluate the specimens of anal fistulas for the presence of multinucleated giant cells and to assess whether any correlation existed between giant cell presence and fistula recurrence. Design: Prospective cohort study. Patients: Adult patients with intersphincteric perianal fistulas included. Patients with recurrent fistulas, Crohn’s disease, tuberculosis, malignancy, immunocompromised status, pregnancy, or those who declined surgical intervention were excluded. A total of 62 patients were included in the final analysis. Interventions: Fistulotomy and open biopsy taken from the fistula tract. Main Outcome Measures: Postoperative recurrence rates, presence of multinucleated giant cells in the sampled fistula tracts, and the association between giant cell presence and fistula recurrence. Results: After 6 months of follow-up, healing was achieved in 52 patients (84%), while fistula persistence was observed in 10 patients (16%) and considered as recurrence. Giant cells were significantly higher in the recurrence group, whereas age, gender, ASA score, and comorbidity did not differ significantly between recurrence and non-recurrence groups. Giant cell presence was observed in 3 patients (5.8%) without recurrence compared to 4 patients (40.0%) with recurrence (p = 0.01). Other histological markers showed no significant difference between the groups. Conclusions: Our study demonstrates that giant cell presence represents a significant predictor of recurrence in primary cryptoglandular intersphincteric anal fistula.
SUMMARY OBJECTIVE: The aim of the study was to examine the effectiveness of adding indocyanine green fluorescence to the dual method, (Radioisotope+Isosulfanblue) for sentinel lymph node biopsy after neoadjuvant chemotherapy (on sentinel lymph nodes identification). METHODS: The 101 patients included in the study were randomized equally into each group. Dual method containing indocyanine green (group 1) or dual method alone (group 2) was used for sentinel lymph node mapping. RESULTS: The sentinel lymph node identification rate was 86.9% in the dual method group and 94.6% in the triple method group. The detection rates of two or more sentinel lymph nodes were 82.6% in the dual group and 89.2% in the triple group. There was no statistically significant difference between both the groups (p>0.05). CONCLUSION: Indocyanine green-based sentinel lymph node biopsy detection will bring a significant change in the management of patients in centers where there is no access to a nuclear medicine department. Nevertheless, multicenter studies with larger patient samples are needed to confirm our results.